-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James
-
-
-
-
-
-
-
FDA approves first treatment for Alexander disease
-
-
-
-
-
-
-
Ionis Pharmaceuticals chief scientific officer to retire in 2027
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Lowered to $100 at Citi
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Ionis Pharmaceuticals (IONS)
-
-
-
-
-
-
-
Ionis Pharmaceuticals (IONS) PT Raised to $100 at RBC Capital
-
475,510 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


